Former General Sees Pentagon Tightening Anthropic Grip
A high-stakes clash between Anthropic and the Pentagon nears a Friday deadline, drawing attention from markets and pe...
Variance In Long Term Returns Across Index Funds
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articles
Billionaire Andreas Halvorsen Just Bets on Recovery Stocks
Investors watch the moves of billionaires to learn how they navigate risk and opportunity. This piece breaks down how...
Engineers, Not Business Operators: Loopring Shuts DEX
Loopring has halted trading on its decentralized exchange, citing outdated zkRollup tech and a strategic pivot toward...
Beijing’s Dominance in Rare Earth Reshapes Markets
Beijing maintains tight control over rare earth processing, forcing investors and policymakers to rethink diversifica...
Three Driving Forces Behind Amplify IDVO's 5.1% Yield Surge
Amplify IDVO is delivering a 5.1% yield through a tri-source income model. This piece explains the three driving forc...
Chris Olah? Atheist Anthropic Co-Founder at Vatican
A high-profile Vatican briefing on AI risk spotlights Chris Olah, the atheist Anthropic co-founder, urging external o...
David Tepper Cuts Microsoft, Ackman Bets Big in AI Push
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
Dawson’s Daughter Charlotte Says Father’s Day Hits Home—Finances
Father’s Day can sting when a parent is gone. This article uses dawson’s daughter charlotte says to explore how memor...
Chair Nominee Kevin Warsh's Biggest Challenge Beyond Rates
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
Suro Capital (SSSS) 2025 Q4 Earnings Deep Dive
As SuRo Capital releases its Q4 2025 results, investors need a clear playbook. This deep dive breaks down the key met...
Micron's Stock 861% Over: Analysts See 30% Upside Ahead
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status